Back to top

Image: Shutterstock

Top Ranked Value Stocks to Buy for September 24th

Read MoreHide Full Article

Here are four stocks with buy rank and strong value characteristics for investors to consider today, September 24th:

Cowen Inc. (COWN - Free Report) : This investment banking, research, sales and trading provider has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 4.7% over the last 60 days.

Cowen has a price-to-earnings ratio (P/E) of 2.41, compared with 15.90 for the industry. The company possesses a Value Score of B.

StealthGas Inc. (GASS - Free Report) : This seaborne transportation services provider has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising more than 100% over the last 60 days.

StealthGas has a price-to-earnings ratio (P/E) of 4.32, compared with 5.90 for the industry. The company possesses a Value Score of A.

Dynagas LNG Partners LP (DLNG - Free Report) : This seaborne transportation operator has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 24.6% over the last 60 days.

Dynagas LNG has a price-to-earnings ratio (P/E) of 3.39, compared with 6.90 for the industry. The company possesses a Value Score of A.

360 Finance, Inc. (QFIN - Free Report) : This digital consumer finance platform has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 20.3% over the last 60 days.

360 Finance has a price-to-earnings ratio (P/E) of 4.18, compared with 71.90 for the industry. The company possesses a Value Score of A.

See the full list of top ranked stocks here.

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>